Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Symposium explores animal welfare and research
The School of Clinical Sciences won first prize for developing a refined method for producing aortic aneurysms in mice.
Researchers share best practice of the ‘3Rs’

The first Animal Welfare and Research '3Rs' symposium was held at the University of Bristol last month, giving scientists the chance to learn about current research and share good practice of the ‘3Rs’: Replace, Reduce and Refine.

Developed more than 50 years ago, the principles of the 3Rs are rooted in European and UK law. When researchers use animals, they must follow the ‘3Rs’ - aiming to replace them, where possible, with alternatives, reduce the number of animals used and to refine their experiments to reduce any adverse effects.

Dr Nicola Watts, director of services at the university, commented: “All our scientists who work with laboratory animals at the university are committed to the '3Rs' and events like this symposium enable the sharing of good practice.”

During the symposium, there were presentations about current research projects and a researcher poster session. The university also announced the winners of its first '3Rs' competition.

The School of Clinical Sciences won first prize for developing a refined method for producing aortic aneurysms in mice. An aortic aneurysm is a bulge in a section of the aorta which, if it ruptures, can cause sudden death. The researchers have also developed a new human aortic aneurysm model in the laboratory, which may replace the need for animal models.

Second prize went to the School of Physiology Pharmacology & Neuroscience, which has developed a method for giving oral drugs using solutions that mice and rats both like. The method, which includes solutions like milk and milkshake, avoids the need for restraint and reduces stress in the animals.

The School of Clinical Sciences also scooped the third prize for developing photographic techniques that can be used in conscious animals. The new technique has revolutionised pre-clinical eye research and cut the number of animals required.

“Animal research plays an essential role in advancing science and treating major health problems," explained Professor John Iredale, vice-chancellor for health at the university. "Despite the advances in non-animal methods, it is still essential to use animals where no viable alternatives exist."

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'